Please submit the form below to register.
Market access is a key area for any life sciences company, and developing an evidence generation strategy is paramount for market access success. To help achieve market access success, real world data (RWD) is able to provide direct insight into the daily application of a drug or medical device. Once RWD is gathered, real world evidence (RWE) can be developed to publish your value proposition in the peer-reviewed literature and facilitate payer coverage and key opinion leader (KOL)/provider adoption. When used in an evidence generation strategy, RWE can effectively communicate product value to your desired stakeholders.